• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒口咽癌中的成纤维细胞生长因子受体(FGFR)改变。

Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers.

机构信息

Department of Medical Oncology, Ohio State University, James Cancer Center, Columbus, Ohio, USA.

Department of Pathology, Ohio State University, James Cancer Center, Columbus, Ohio, USA.

出版信息

J Med Virol. 2024 Nov;96(11):e70086. doi: 10.1002/jmv.70086.

DOI:10.1002/jmv.70086
PMID:39564895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11600385/
Abstract

HPV viral E6 and E7 onco-proteins play a well-known role in carcinogenesis. Host genomic alterations also play a key role in the development of HPV-related oropharyngeal cancer and have been under-recognized. We describe a case series of 6 metastatic/locoregionally recurrent HPVOPSCC patients with FGFR alterations. HPVOPSCC presents with distinct pattern of spread both temporally and sites of recurrence compared to  non-HPV-related oropharyngeal cancer. Identification and reporting of genomic alterations in HPV are crucial to the understanding of disease biology and could aid in development of novel therapeutics for these patients. In addition, use of circulating tumor DNA may lead to early detection and supplement imaging in the follow up of these patients. Loco-regional treatments may also play a key role in the management of metastatic HPV OPSCC depending on the pattern of presentation. Our case series highlights all these novelties that could lead to better treatment outcomes.

摘要

HPV 病毒 E6 和 E7 致癌蛋白在致癌作用中起着众所周知的作用。宿主基因组改变在 HPV 相关口咽癌的发展中也起着关键作用,但尚未得到充分认识。我们描述了 6 例转移性/局部复发性 HPV 口咽癌患者伴 FGFR 改变的病例系列。与非 HPV 相关的口咽癌相比,HPV 口咽癌在时间和复发部位上具有不同的扩散模式。HPV 中基因组改变的识别和报告对于了解疾病生物学至关重要,并可能有助于为这些患者开发新的治疗方法。此外,循环肿瘤 DNA 的使用可能会导致这些患者的早期检测,并在随访中补充影像学检查。局部区域治疗也可能根据表现模式在转移性 HPV 口咽癌的治疗中发挥关键作用。我们的病例系列强调了所有这些新的发现,这些发现可能会带来更好的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/11600385/c9fa96d6a645/JMV-96-e70086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/11600385/a29624bf0197/JMV-96-e70086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/11600385/c9fa96d6a645/JMV-96-e70086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/11600385/a29624bf0197/JMV-96-e70086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/11600385/c9fa96d6a645/JMV-96-e70086-g001.jpg

相似文献

1
Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers.人乳头瘤病毒口咽癌中的成纤维细胞生长因子受体(FGFR)改变。
J Med Virol. 2024 Nov;96(11):e70086. doi: 10.1002/jmv.70086.
2
HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.HPV16 E6/E7 表达在口咽鳞状细胞癌循环肿瘤细胞中的研究:一项初步研究。
PLoS One. 2019 May 9;14(5):e0215984. doi: 10.1371/journal.pone.0215984. eCollection 2019.
3
Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.HPV16 E2 结合位点的甲基化状态可对 HPV 相关口咽癌的亚型进行分类。
Cancer. 2015 Jun 15;121(12):1966-76. doi: 10.1002/cncr.29315. Epub 2015 Mar 2.
4
Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.形态蛋白质组学、E6/E7 原位杂交和生物医学分析定义了 HPV 相关口咽癌的病因发病机制,并提供了靶向治疗选择。
J Otolaryngol Head Neck Surg. 2017 Aug 17;46(1):52. doi: 10.1186/s40463-017-0230-2.
5
The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.人乳头瘤病毒诱导头颈部鳞状细胞癌发生癌变的分子机制。
Int J Clin Oncol. 2016 Oct;21(5):819-826. doi: 10.1007/s10147-016-1005-x. Epub 2016 Jun 23.
6
Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.人乳头瘤病毒在口咽鳞状细胞癌中的研究:评估正常组织中的病毒存在情况及颈转移灶中的病毒活性。
Laryngoscope. 2012 Dec;122(12):2707-11. doi: 10.1002/lary.23516. Epub 2012 Sep 7.
7
Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma.血浆游离型人乳头瘤病毒致癌基因 E6 和 E7 DNA 可预测口咽鳞状细胞癌的预后。
J Mol Diagn. 2020 Nov;22(11):1333-1343. doi: 10.1016/j.jmoldx.2020.08.002. Epub 2020 Aug 18.
8
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.E6和E7抗体水平是晚期人乳头瘤病毒阳性口咽鳞状细胞癌患者复发的潜在生物标志物。
Clin Cancer Res. 2017 Jun 1;23(11):2723-2729. doi: 10.1158/1078-0432.CCR-16-1617. Epub 2016 Nov 21.
9
A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis.一种新型 RT-PCR 方法,用于定量检测存档组织中的人乳头瘤病毒转录本及其在口咽癌预后中的应用。
Int J Cancer. 2013 Feb 15;132(4):882-90. doi: 10.1002/ijc.27739. Epub 2012 Sep 7.
10
Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.应用液滴数字聚合酶链反应检测口咽鳞癌中人乳头瘤病毒 16 型。
Cancer. 2016 May 15;122(10):1544-51. doi: 10.1002/cncr.29976. Epub 2016 Mar 17.

本文引用的文献

1
Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.人乳头瘤病毒循环肿瘤DNA:一种用于原发灶不明的鳞状细胞癌的诊断工具——一项初步研究
Front Oncol. 2024 Apr 2;14:1376595. doi: 10.3389/fonc.2024.1376595. eCollection 2024.
2
Association of circulating tumor HPV16DNA levels and quantitative PET parameters in patients with HPV-positive head and neck squamous cell carcinoma.循环肿瘤 HPV16DNA 水平与 HPV 阳性头颈部鳞状细胞癌患者定量 PET 参数的相关性。
Sci Rep. 2024 Feb 8;14(1):3278. doi: 10.1038/s41598-024-53894-4.
3
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
人乳头瘤病毒循环肿瘤 DNA 用于宫颈癌放化疗后残余疾病早期检测的临床验证。
J Clin Oncol. 2024 Feb 1;42(4):431-440. doi: 10.1200/JCO.23.00954. Epub 2023 Nov 16.
4
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.FGFR3 改变的尿路上皮癌的临床和基因组特征及厄达替尼治疗的结果:真实世界经验。
Clin Cancer Res. 2023 Nov 14;29(22):4586-4595. doi: 10.1158/1078-0432.CCR-23-1283.
5
Global epidemiologic patterns of oropharyngeal cancer incidence trends.口咽癌发病率趋势的全球流行病学模式。
J Natl Cancer Inst. 2023 Dec 6;115(12):1544-1554. doi: 10.1093/jnci/djad169.
6
Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium.寡转移头颈部癌立体定向体部放疗的结果:来自一个国际多机构联盟的结果。
Head Neck. 2023 Oct;45(10):2627-2637. doi: 10.1002/hed.27488. Epub 2023 Aug 21.
7
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.厄达替尼治疗 FGFR 改变的晚期实体瘤患者(RAGNAR):一项国际、单臂、2 期研究。
Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9.
8
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.头颈部鳞状细胞癌复发模式,为制定个体化监测方案提供信息。
Cancer. 2023 Sep 15;129(18):2817-2827. doi: 10.1002/cncr.34823. Epub 2023 May 10.
9
Futibatinib for -Rearranged Intrahepatic Cholangiocarcinoma.用于治疗FGFR2重排型肝内胆管癌的futibatinib
N Engl J Med. 2023 Jan 19;388(3):228-239. doi: 10.1056/NEJMoa2206834.
10
Oligometastasis in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌寡转移。
Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):803-811. doi: 10.1016/j.ijrobp.2022.06.086. Epub 2022 Jul 4.